ITI PHARMA AND HEALTHCARE FUND NFO

  (An open ended equity scheme investing in Pharma and Healthcare)

What is ITI Pharma and Healthcare Fund?

• ITI Pharma and Healthcare Fund is a fund which will invest in equity and equity related securities of companies engaged in Pharma and Healthcare.

Why invest in Pharma Fund?

• Benefit from increased importance of Healthcare in the post Covid-19 Era
• Flexibility to invest across market caps and investing styles to optimize risk return payoffs
• Diversification benefits with Healthcare sub-sectors
• Potentially lower volatility as historically seen in this sector as it is a defensive play
• Capitalize on changing trends that are reshaping the global Pharma and Healthcare industry

Product features

• Exposure to one of the most rapidly growing & evolving businesses in India
• Market Cap Agnostic approach to Portfolio Construction
• Allocations across healthcare ecosystem like Domestic Pharma, Global Pharma, Diagnostics, Hospitals, Wellness and medical devices
• The fund can be suitable for long-term equity investors who have an investment horizon of 4-5 years at least.
• Bottom up valuation based approach to analyze business and market cycles

NFO Details

New Fund Offer Opens on	October 18, 2021
New Fund Offer Closes on	November 01, 2021
Scheme reopens for continuous sale and repurchase on or before	November 17, 2021

Name of the Scheme	ITI Pharma and Healthcare Fund
Type of Scheme	An open ended equity scheme investing in Pharma and Healthcare
Investment objective	The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Minimum application amount	Rs. 5,000/- and in multiples of Rs. 1/- thereafter

ASSET ALLOCATION

Instruments	Indicative Allocation (% of net assets)		Risk Profile
	Maximum	Minimum	Low / Medium / High
Equity & Equity related instruments of companies engaged in Pharma and Healthcare	100%	80%	High
Equity and Equity related securities of other Companies	20%	0%	High
Listed Preference Shares	10%	0%	Medium to High
Debt and Money Market Instruments	20%	0%	Low to Medium
Units issued by REITs and InvITs	10%	0%	Medium to High

KEY FEATURES

• Exposure
• Exposure to one of the most rapidly growing and evolving businesses in India
• Suitability
• The fund can be suitable for long-term equity investors who have an investment horizon of 4-5 years atleast
• Allocation
• Allocations across healthcare ecosystem like Domestic Pharma, Global Pharma, Diagnostic, Hospitals, wellness and medical devices
• Valuation Approach
• Bottom up valuation based approach to analyse business and market cycle